Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Aug. 01, 2026
Aug. 02, 2025
Operating activities    
Net income $ 622,475 $ 565,927
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 162,724 143,198
Non-cash lease expense 178,326 183,528
Deferred income taxes 1,524 2,232
Stock-based compensation expense 21,063 20,338
Loss on disposal of property and equipment 8,404 4,689
Equity net loss of affiliate 3,652 1,225
Change in operating assets and liabilities:    
Receivables 47,127 (198)
Merchandise inventories (226,791) (366,091)
Prepaid expenses and other current assets 5,645 (21,657)
Income taxes (68,104) (70,406)
Accounts payable (47,328) 98,115
Accrued liabilities (120,902) (3,881)
Deferred revenue (39,821) (44,418)
Operating lease liabilities (178,756) (180,316)
Other assets and liabilities 12,352 (15,742)
Net cash provided by operating activities 381,590 316,543
Investing activities    
Proceeds from short-term investments 15,000  
Capital expenditures (139,534) (155,988)
Acquisitions, net of cash acquired   (386,793)
Other investments (9,446) (17,130)
Net cash used in investing activities (133,980) (559,911)
Financing activities    
Borrowings from short-term debt 1,358,274 593,641
Payments on short-term debt (1,080,032) (333,100)
Repurchase of common shares (793,183) (479,242)
Stock options exercised 12,904 14,851
Purchase of treasury shares (10,876) (13,238)
Net cash used in financing activities (512,913) (217,088)
Effect of exchange rate changes on cash and cash equivalents (489)  
Net decrease in cash and cash equivalents (265,792) (460,456)
Cash and cash equivalents at beginning of period 424,243 703,201
Cash and cash equivalents at end of period 158,451 242,745
Supplemental information    
Income taxes paid, net of refunds 264,270 252,013
Non-cash investing and financing activities:    
Non-cash capital expenditures 47,417 62,621
Repurchase of common shares in accrued liabilities $ 2,000 $ 3,998